KNOWLEDGE BANK

Interviews

Porton Pharma Solutions and Codexis Launch Global Partnership

PARTNERSHIP
Codexis Inc and Porton Pharma Solutions Ltd announce a strategic collaboration to deploy Codexis worldleading biocatalyst technology within Portons global custom intermediate and active pharmaceutical ingredients API development and manufacturing business The partnership will accelerate the creation and commercialization of new lowcost sustainable manufacturing processes exploiting the benefits of...

Articles

Role of Nutraceutical in Various Diseases - A Review

DeFelice introduced the term nutraceutical in combining the words nutrition and pharmacy and originally defined it as a food or part of a food that provides medical or health benefits including the prevention and treatment of disease A nutraceutical may be a nutrientdense food like spirulina garlic or soy or a specific dietary component

Research Insights

The Promises Of Quantitative Systems Pharmacology Modelling For Drug Development

Abstract Recent growth in annual new therapeutic entity NTE approvals by the US Food and Drug Administration FDA suggests a positive trend in current research and development RD output Prior to this the cost of each NTE was considered to be rising exponentially with compound failure occurring mainly in clinical phases Quantitative Systems Pharma

Case Studies

Tablet Coating at Low Bed Temperatures with a Novel Coating Polymer

This study shows how to obtain elegant uniform coatings with zero visible defects and a practical coating solution for heat sensitive products For More Infromation Click Here

Techno Trends

RefleXion Medical Developed First-of-its-Kind SCINTIX Biology-guided Radiotherapy

RefleXion Medical has achieved a significant milestone by successfully treating a patient using groundbreaking SCINTIX biologyguided radiotherapy

White Papers

Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches

In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS

TOP ARTICLES

1

Applying Human Factors Engineering to Generic Combination Products

Frauke Schuurkamp

Frauke Schuurkamp has 12 years of experience delivering HFE services to the medical and pharmaceutical industries. Schuurkamp conducts HFE workshops, advises on HFE strategies, leads research and analysis activities and develops key deliverables to support FDA and international regulatory submissions. Schuurkamp holds a bachelor’s degree in applied psychology and a master’s degree in human factors psychology. 

Lisanne de Vogel

Lisanne de Vogel has 7+ years of experience delivering HFE services to the medical device and pharmaceutical industries. Lisanne leads and oversees human factors research activities, such as usability testing, and helps clients develop key HFE documents for their (international) regulatory submissions, as well as advising them on how to apply HFE during product development to meet regulators' expectations. She holds a bachelor’s degree in Communication Science and a master’s degree in Applied Cognitive Psychology. 

2

Pharma Regulatory Bottlenecks and Vaccination Delays

Sonam Chandwani

Sonam Chandwani is the Managing Partner at KS Legal & Associates. Her experience encompasses commercial and crosses border transactions across various sectors, advising both Indian companies in their outbound investments and foreign companies investing in India, on diverse areas of Indian laws concerning Mergers & Acquisitions, Insolvency & Bankruptcy, Banking & Finance, Real Estate, Arbitration and Litigation in Courts and Tribunals on a PAN-India basis.

 

3

Automation in Pharmaceutical Sector by Implementation of Artificial Intelligence

Amol Shinde

Amol Shinde is Assistant Manager in Department of Medical Affairs and Pharmacovigilance at Unichem Laboratories Ltd., India with approx. 7 years of working experience in various corporate of pharma industries. He has published 4 papers in international and national journals.

 

4

Chemistry & AI

Ashok Kumar

Dr. Ashok Kumar FRSC, President of the Centre for Research & Development at Ipca, earned his PhD from CDRI with Dr. Nityanand and post-doctoral experience from Sussex University with Nobel Laureate Prof. Cornforth. His interests include Chemical, Biotechnological & NDDR research and also integrating spirituality, philosophy, and common sense in his professional and personal life.

5

Evolution of eCTD from version 1 to 4

Gouspasha Mohammed

Gouspasha is a seasoned professional with 12 years of experience in the pharmaceutical industry, specializing in eCTD (Electronic Common Technical Document) publishing and submission. With a strong focus on regulatory compliance and efficient document management, Gouspasha ensures seamless and timely submissions. Dedicated to maintaining the highest standards of quality and accuracy, Gouspasha remains committed to staying current with evo0lving industry trends and regulatory requirements.

press releasesRead more...

Samsung Bioepis Launches OPUVIZ™ (Aflibercept) 40 mg/mL Pre-filled Syringe Across Europe

Samsung Bioepis Co Ltd today announced the launch of OPUVIZ mgmL solution in prefilled syringe PFS a biosimilar referencing Eylea aflibercept across Europe starting today

Akeso Advances IO2.0 + ADC2.0 Strategy: First Patient Dosed in Phase II Study of TROP2/Nectin-4 Bispecific ADC (AK146D1) Combined with Ivonescimab in Breast Cancer

Akeso Inc HK Akeso or the Company today announced that the first patient has been dosed in a Phase II clinical study AKD evaluating AKD the Companys internally developed TROPNectin

Sobi enters strategic partnership with Innate Pharma to license lacutamab in T-cell lymphoma

Swedish Orphan Biovitrum AB publ Sobi and Innate Pharma SA Euronext Paris IPH Nasdaq IPHA Innate or the Company today announced that they have entered a strategic partnership to enable initiation

Nicox Announces NCX 470 NDA Submission in China by Partner Ocumension

Nicox SA Euronext Growth Paris FR ALCOX an international ophthalmology company today announced that its exclusive licensee in China Ocumension Therapeutics has submitted the New Drug Application

Mediar Therapeutics Enters into a Collaboration and Option Agreement with Ono Pharma to Develop Novel Treatments for Fibro-inflammatory Diseases

Mediar Therapeutics Inc a clinicalstage biotechnology company pioneering firstinclass therapies to halt and reverse fibrosis has entered into a collaboration and option agreement with Ono Pharmaceutical Co

Chugai and UCSF Establish Master Collaboration Agreement for Drug Discovery Research - A Framework to Streamline Future Research Projects-

Chugai Pharmaceutical Co Ltd TOKYO hereafter Chugai and the University of California San Francisco UCSF have entered into a Master Collaboration Agreement to advance drug discovery research

EventsRead more...

11 - 12

Aug 2026

19 - 21

Aug 2026

20 - 21

Aug 2026

20 - 21

Aug 2026

20 - 21

Aug 2026

25 - 27

Aug 2026

CPHI Korea 2026

COEX, Seoul, Korea

26 - 27

Aug 2026

BIOMEDevice 2026

Boston Convention & Exhibition...

03 - 05

Sep 2026

5th MENA Congress for Rare Diseases 2026

Beach Rotana Hotel, Abu Dhabi,...

LATEST NEWSRead more...

Innovent Biologics and Daiichi Sankyo Sign Exclusive China Commercialisation Agreement for VANFLYTA®

Innovent Biologics and Daiichi Sankyo have entered into an exclusive agreement for the commercialisation of VANFLYTA quizartinib in China

Argenx Launches Tender Offer to Acquire Forte Biosciences

Argenx has commenced a tender offer to acquire all outstanding shares of Forte Biosciences through its wholly owned subsidiary Avena Merger Sub Inc The offer values Fortes common shares at US per

GenScript and Tamarind Bio partner to link AI molecular design with wet-lab validation

GenScript Biotech Corporation and Tamarind Bio have entered into a strategic partnership to combine AIpowered molecular design with rapid wetlab validation aiming to streamline the drug discovery process

Phylo and Chugai collaborate to deploy AI platform for drug discovery

Phylo has entered into a collaboration with Chugai Pharmaceutical to deploy Biomni Lab its agentic AI platform for biomedical research across Chugais drug discovery programmes

Amplia Enters into Collaboration with Lilly to Evaluate Narmafotinib in Lung Cancer Trial

Amplia Therapeutics has entered into a Clinical Trial Collaboration and Supply Agreement with Eli Lilly and Company to evaluate its investigational focal adhesion kinase FAK inhibitor narmafotinib

Fujifilm and Taiho Pharmaceutical Partner to Advance Next-Generation ADC Manufacturing

FUJIFILM and Taiho Pharmaceutical have formed a strategic partnership to develop manufacturing technologies for nextgeneration antibodydrug conjugates ADCs